People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Pharma, Investment Vehicle, Biotechnology, Other Health Care, Other, Hospitals and Physicians
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osteon Holdings, Inc. | — | Pharma | Growth/Late | $617.0M | $22.4B | 2018 |
| Opry Investment Holdings I, LLC | — | Investment Vehicle | Series D+ | $202.7M | $2.3B | 2023 |
| Asklepios BioPharmaceutical, Inc. | — | Biotechnology | Series D+ | $199.7M | $8.2B | 2019 |
| KSMS Holdings, LLC | — | Other Health Care | Series B | $40.0M | $885.1M | 2020 |
| BVI Audley, Inc. | — | Other | Series B | $33.6M | $241.0M | 2016 |
| Kelsey-Seybold Medical Group, PLLC | — | Hospitals and Physicians | Series A | $14.2M | $267.0M | 2020 |
John Schilling at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Schilling on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kendall Garrison | 4 | 7 |
| Jeffrey Rhodes | 2 | 3 |
| Jonathan Nelson | 2 | 3 |
| Maher Daas | 2 | 2 |
| Azam Kundi | 2 | 2 |
| Benjamin Dillon | 2 | 2 |
| Donnie Aga | 2 | 2 |
| Tony Lin | 2 | 2 |
| Jack Larsen | 2 | 2 |
| Victor Simms | 2 | 2 |
| Fred Cohen | 1 | 12 |
| Dana G. Mead, Jr. | 1 | 7 |
| Robert Turner | 1 | 6 |
| WILLIAM H. FRIST | 1 | 6 |
| Jon Salveson | 1 | 5 |
| STEVEN A. WILLMANN | 1 | 4 |
| CLIVE BODE | 1 | 4 |
| Jeffrey Binder | 1 | 3 |
| Joann Harris | 1 | 3 |
| Ken Murphy | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.